Keywords: Sanofi-Aventis, Sanofi Pasteur, Crucell, Vaccines, Investment in Massachusetts, Licensing

Sanofi-Aventis unit returns rights for pediatric and respiratory vaccines to Crucell; invests $65 million to expand in USA

Article | 09 July 2010

Print This

Dutch biopharmaceutical company Crucell NV says it has reached agreement with Sanofi Pasteur, part of French drug major Sanofi-Aventis, to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in